Advisor, Upstream Process Development
Eli Lilly and Company
January 2023 – Present
o Leading the design and execution of upstream process development studies in baculovirus/Sf9 systems for AAV gene therapy drug substances in benchtop scale bioreactors
o Developing platform process to screen and optimize process conditions for new pipeline products
o Assisting research material generation needs for new pipeline products
o Providing technical expertise in cell culture scale-up, bioreactor process parameters, process control strategy, and media additive strategies
o Building process understanding to support technology transfer to internal or external groups for manufacturing at pilot, engineering, clinical, or commercial scales
o Developing new production lab to scale up AAV production for rare disease treatment
